John K. Cini - Dec 14, 2022 Form 4 Insider Report for Sonnet BioTherapeutics Holdings, Inc. (SONN)

Role
Chief Scientific Officer
Signature
/s/ John Harry Cross III, power of attorney
Stock symbol
SONN
Transactions as of
Dec 14, 2022
Transactions value $
$0
Form type
4
Date filed
12/22/2022, 03:30 PM
Previous filing
Apr 8, 2022
Next filing
Feb 17, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SONN Common Stock Award +18.6K +6.1% 323K Dec 14, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On December 14, 2022, the Reporting Person was granted 18,551 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units vest as to 100% of the restricted stock units on January 1, 2024.
F2 Includes unvested RSUs.